Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.

Saved in:
Bibliographic Details
Title: Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.
Authors: Rinotas V; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Ntouskou ED; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Dragolia M; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Ntafis V; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Yavropoulou MP; Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Anastasilakis AD; Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece., Makras P; Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force, Veterans Affairs General Hospital, Athens, Greece., Douni E; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.; Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Feb 26; Vol. 17, pp. 1783656. Date of Electronic Publication: 2026 Feb 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41837128
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rinotas+V%22">Rinotas V</searchLink>; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.<br /><searchLink fieldCode="AU" term="%22Ntouskou+ED%22">Ntouskou ED</searchLink>; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.<br /><searchLink fieldCode="AU" term="%22Dragolia+M%22">Dragolia M</searchLink>; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.<br /><searchLink fieldCode="AU" term="%22Ntafis+V%22">Ntafis V</searchLink>; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.<br /><searchLink fieldCode="AU" term="%22Yavropoulou+MP%22">Yavropoulou MP</searchLink>; Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Anastasilakis+AD%22">Anastasilakis AD</searchLink>; Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Makras+P%22">Makras P</searchLink>; Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force, Veterans Affairs General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Douni+E%22">Douni E</searchLink>; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.; Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2026 Feb 26; Vol. 17, pp. 1783656. <i>Date of Electronic Publication: </i>2026 Feb 26 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41837128
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2026.1783656
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1783656
    Titles:
      – TitleFull: Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rinotas V
      – PersonEntity:
          Name:
            NameFull: Ntouskou ED
      – PersonEntity:
          Name:
            NameFull: Dragolia M
      – PersonEntity:
          Name:
            NameFull: Ntafis V
      – PersonEntity:
          Name:
            NameFull: Yavropoulou MP
      – PersonEntity:
          Name:
            NameFull: Anastasilakis AD
      – PersonEntity:
          Name:
            NameFull: Makras P
      – PersonEntity:
          Name:
            NameFull: Douni E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 02
              Text: 2026 Feb 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1664-2392
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in endocrinology
              Type: main
ResultId 1